Amneal Pharmaceuticals In... (AMRX)
NASDAQ: AMRX
· Real-Time Price · USD
9.34
-0.05 (-0.53%)
At close: Aug 15, 2025, 2:17 PM
Amneal Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 51.24M | 32.42M | -73.88M | -146.48M | -133.2M | -120.31M | -48.72M | 38.76M | 11.34M | -258.42M | -254.79M | -269.39M | -273.09M | -835K | 20.17M | 33.67M | 17.73M | -38.39M |
Depreciation & Amortization | 245.36M | 240.82M | 236.19M | 226.99M | 225.24M | 226.78M | 229.4M | 233.52M | 237.93M | 240.51M | 240.18M | 240.3M | 238.88M | 235.67M | 233.41M | 232.1M | 231.27M | 232.85M |
Stock-Based Compensation | 29.85M | 28.3M | 27.77M | 26.53M | 26.11M | 25.95M | 26.82M | 28.68M | 29.68M | 31.38M | 31.85M | 31.76M | 31.78M | 31.15M | 28.41M | 25.8M | 23.51M | 21.54M |
Other Working Capital | 47.56M | 57.99M | 53.42M | 37.51M | 13.13M | 9.64M | -7.13M | 18.57M | 105.88M | 102.02M | 125.71M | 87.95M | 4.21M | -20.48M | -17.02M | -9.02M | 115.66M | 172.21M |
Other Non-Cash Items | 101.48M | 103.84M | 109.08M | 168.14M | 174.16M | 172.62M | 175.4M | 121.61M | 115.41M | 102.88M | 83.36M | 28.22M | 26.19M | 26.6M | 19.94M | 33.99M | 18.83M | 34M |
Deferred Income Tax | n/a | n/a | n/a | 9.88M | 7.81M | 7.81M | 7.81M | -2.08M | n/a | n/a | n/a | 42.8M | 46.84M | 59.43M | 73.48M | 42.5M | 83.27M | 72.87M |
Change in Working Capital | -76.86M | -98.47M | -4.07M | 27.78M | -49.73M | -113.44M | -47.19M | -236.09M | -195.69M | -56.32M | -59.95M | 53.52M | 45.4M | -137.98M | -133.59M | -83.54M | -127.67M | 155.23M |
Operating Cash Flow | 351.08M | 306.92M | 295.1M | 312.84M | 252.46M | 201.46M | 345.58M | 186.46M | 198.65M | 84.47M | 65.1M | 151.65M | 140.45M | 214.03M | 241.82M | 284.52M | 246.93M | 478.1M |
Capital Expenditures | -88.6M | -73.55M | -74.99M | -63.72M | -56.48M | -57.31M | -49.29M | -48.96M | -84.82M | -89.65M | -90.59M | -98.38M | -60.68M | -52.63M | -52.64M | -65.18M | -70.97M | -70.46M |
Cash Acquisitions | 855K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -84.71M | -157.43M | -157.43M | -231.26M | -146.54M | -73.83M | -71.19M | 2.27M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.83M | 2.41M | -2.66M | -28.96M | -26.36M | -31.75M | -22.39M | -46.68M | -77.48M | -85.33M | -169.7M | -120.51M | -88.71M | -154.04M | -70.25M | -76.34M | -75.91M | -1.95M |
Investing Cash Flow | -81.12M | -61.03M | -63M | -78.63M | -71.39M | -77.21M | -69.19M | -48.96M | -84.82M | -88.65M | -174.31M | -249.81M | -212.11M | -278.88M | -194.18M | -139.01M | -142.16M | -68.2M |
Debt Repayment | -177.57M | -187.27M | -185.12M | -392.15M | -368.89M | -356.8M | -414.08M | -169.16M | -147.83M | -101.14M | -38.27M | -30.46M | -22.22M | -64.25M | -78.18M | -78.04M | -53.38M | -353.31M |
Common Stock Repurchased | -22.22M | -22.38M | -7.95M | -5.53M | -5.53M | -5.38M | -189K | -2.31M | -2.31M | -2.59M | -3.57M | -3.55M | -3.58M | -3.56M | -2.66M | -2.66M | -2.68M | -2.46M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -57.75M | -40.76M | -26.83M | 140.93M | 123.42M | 134.17M | 203.73M | 37.48M | 56.6M | 45.4M | -68.16M | -84.15M | -89.79M | -109.07M | -59.73M | -40.79M | -36.93M | -9.01M |
Financial Cash Flow | -234.4M | -227.8M | -211.79M | -251.42M | -245.66M | -222.83M | -212.57M | -133.91M | -93.45M | -57.95M | -106.62M | -114.8M | -112.23M | -173.54M | -138.12M | -119.05M | -90.31M | -362.32M |
Net Cash Flow | 34.19M | 16.78M | 19.31M | -17.26M | -64.96M | -99.45M | 63.88M | -284K | 16.4M | -65.48M | -221.51M | -214.73M | -184.97M | -239.27M | -90.38M | 26.97M | 14.88M | 48.89M |
Free Cash Flow | 262.48M | 233.37M | 220.11M | 229.23M | 176.07M | 124.24M | 276.39M | 137.5M | 113.83M | -5.18M | -25.5M | 53.27M | 79.76M | 161.41M | 189.18M | 219.34M | 175.96M | 407.64M |